Johnson & Johnson , the world’s biggest maker of health-care products, was cited by U.S. regulators over violations at a plant where the company suspended over-the-counter drug production earlier this year.
Johnson & Johnson , the world’s biggest health products maker, will face more scrutiny from U.S. regulators after its McNeil unit was charged with violating federal laws following multiple recalls in the past year of over-the-counter drugs such as Tylenol.
Metro-Goldwyn-Mayer Inc . held its first Chapter 11 hearing yesterday and the bankruptcy judge set aside Dec. 2 for a confirmation hearing to consider approving the reorganization plan that creditors accepted in advance.
Companies in the Standard & Poor’s 500 Index are paying less in interest on debt than any time in at least a decade, leaving investors more dependent on economic growth and corporate spending for equity gains in 2013.
Global stocks slid for a seventh day, the longest slump since November, amid concern a faltering economic recovery will hurt corporate profits. The euro fell to a two-year low, the yen and dollar gained and government bond yields from Germany to South Korea fell to records.
Johnson & Johnson may have used bacteria-tainted materials in making more than 40 types of children’s pain and allergy medicines recalled last week, U.S. regulators said, prompting a congressional inquiry.